Alerts will be sent to your verified email
Verify EmailSANOFICONR
|
Sanofi Cons. Health
|
Sanofi India
|
Viyash Scientific
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
72.87 % | 52.02 % | -0.13 % |
|
5yr average Equity Multiplier
|
1.82 | 4.62 | 2.16 |
|
5yr Average Asset Turnover Ratio
|
1.48 | 0.47 | 0.95 |
|
5yr Avg Net Profit Margin
|
27.34 % | 24.38 % | 0.03 % |
|
Price to Book
|
36.19 | 10.79 | 11.7 |
|
P/E
|
42.68 | 22.46 | 123.29 |
|
5yr Avg Cash Conversion Cycle
|
-83.69 Days | 4.83 Days | 49.09 Days |
|
Inventory Days
|
47.09 Days | 66.8 Days | 80.25 Days |
|
Days Receivable
|
10.93 Days | 31.98 Days | 79.76 Days |
|
Days Payable
|
135.97 Days | 63.37 Days | 114.46 Days |
|
5yr Average Interest Coverage Ratio
|
32.14 | 906.11 | 1.93 |
|
5yr Avg ROCE
|
99.14 % | 27.19 % | 6.67 % |
|
5yr Avg Operating Profit Margin
|
38.38 % | 24.71 % | 7.74 % |
|
5 yr average Debt to Equity
|
0.0 | 0.0 | 0.53 |
|
5yr CAGR Net Profit
|
1.88 % | 31.63 % | -25.52 % |
|
5yr Average Return on Assets
|
40.56 % | 11.5 % | 0.05 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
71.27 % | 60.4 % | 61.41 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
10.87 % | 0.0 | 8.62 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.4 % | 0.06 % | 5.57 % |
|
Sanofi Cons. Health
|
Sanofi India
|
Viyash Scientific
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|